Tolerability & Pharmacokinetics of Ginkgolide B Injection: Single- and Multiple-Ascending Doses in Healthy Subjects

NCT07457008 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: The 10mg dose group
DRUG: The 20mg dose group
DRUG: The 30mg dose group
OTHER: The Placebo group

Sponsor

West China Second University Hospital